AIRDUO RESPICLICK
Fluticasone propionate / Salmeterol · Teva Pharmaceuticals
Discontinued by manufacturer
Teva discontinued branded AirDuo RespiClick effective July 9, 2025 (business decision, not safety-related). An identical authorized generic (fluticasone propionate and salmeterol inhalation powder, Teva) remains available in all three strengths.
Teva discontinuation noticeActive Medication & Mechanism
- Fluticasone propionate ICS55 mcg, 113 mcg, or 232 mcg per inhalation
Synthetic corticosteroid with anti-inflammatory activity. Suppresses inflammatory cells and mediators in the airways.
- Salmeterol xinafoate LABA14 mcg per inhalation
Long-acting beta2-adrenergic agonist. Stimulates beta2-receptors producing sustained bronchodilation (≥12 hours).
FDA-Approved Dosing — Strength × Indication
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
Not a rescue inhaler. Not indicated for acute bronchospasm. Use a SABA.
Related Inhalers
Same active ingredients (Fluticasone/Salmeterol)